Recent research showed that the vaccine for the Epstein Barr virus (EBV) can be used to stimulate immune system to attack cancer cells. EBV is a herpes virus that usually causes no health problems but is related with various cancers and in these cases the tumour cells are infected with the virus.

The new vaccine is supposed to stimulate body’s immune system against tumours and it targets proteins EBNA1 and LMP2 which appear in those cancer cells that are infected with the virus.

First results show that the vaccine can encourage immune system to response to the proteins in the tumour and the next step would be to find a way to attack tumour cells.

Researchers are working on serious of tests with patients with EBV which receive the vaccine three times at three week intervals.

So far, results show that injection did stimulate immune response and it’s likely that the vaccine could be used along with chemotherapy to prevent re - growth of the disease related to the virus.